en · de · es
thymosin-alpha-1-notes.peptides1126.com › Faq › Molecular Structure And Biological Background — Evidence Review

Molecular Structure And Biological Background — Evidence Review

By Editorial Desk · published 2025-07-30 · last reviewed 2025-09-13 · Faq

Everything below concerns immunomodulator. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2025-09-13. Numbers and descriptions here follow the published literature rather than marketing material.

Molecular Structure and Biological Background

Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.

The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.

Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.

Background and Mechanism of Action

Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.

Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.

Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.

Thymosin-alpha-1 at a glance

PropertyValueNotes
Chemical classSynthetic peptide, 28 residuesN-terminal fragment of prothymosin alpha
Molecular massAbout 3108 DaAcetylated form
Isoelectric pointNear 4.2Acidic peptide
AppearanceWhite to off-white lyophilized powderCommon supplied form
Typical storage-20 °C or below, drySolution stability is lower

分子身份与天然来源

胸腺素α1(thymosin alpha 1,Tα1)是一种由28个氨基酸组成的酸性肽,N端被乙酰化,分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离,属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守,提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置,并非表示亚型编号。它既存在于胸腺,也存在于脾脏和淋巴结等免疫组织。

20世纪70年代,研究者从胸腺提取物中纯化出多种小肽,Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤,产量低且成分复杂。随着固相肽合成技术成熟,实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上,并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。

市售的胸腺素α1通常以冻干粉形式提供,溶解后用于注射。其氨基酸组成包括多个酸性残基,因此在中性pH下带负电荷。该肽可溶于水和生理盐水,但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度,溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。

Related pages on this site

Research History and Clinical Assessment

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.

Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.

Background and Molecular Profile

The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.

Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.

The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.

Notes from published material

=== He–Hi === Clayton Heathcock (born 1936), American chemist known for his work on the synthesis of complex polycyclic natural products Alan J. Heeger (1936–2023), American chemist known for co-founding the field of conducting polymers, 2000 Nobel Prize in chemistry Jan Baptist van Helmont (1579–1644), chemist from the Spanish Netherlands known for studying the weight gain of growing plants, The founder of pneumatic chemistry Victor Henri (1872–1940), French physical chemist of Russian parents, the first to apply ideas of physical chemistry to the properties of enzymes. Dudley R.

KFC is a subsidiary of Yum! Brands, one of the largest restaurant companies in the world. KFC had sales of $23 billion in 2013. KFC is incorporated under Delaware General Corporation Law, and has its headquarters at 1441 Gardiner Lane, Louisville, Kentucky, in a three-story colonial style building known colloquially as the "White House" due to its resemblance to the US president's home. The headquarters contain executive offices and the company's research and development facilities. In 2025, Yum! Brands plans to move the KFC headquarters to Plano, Texas.

The distal (lower) third of the rectum (the rectal ampulla) is below the peritoneum. The folding of peritoneum over pelvic structures creates some "pouches". The folding of peritoneum between the anterior surface of the rectum and the uterus is called the rectouterine pouch, or the pouch of Douglas or cul-de-sac. The equivalent structure in males is called the rectovesical pouch (between rectum and bladder). The lateral extension of the rectouterine pouch (or rectovesical pouch in males) around the sides of the rectum is called the pararectal fossa. The mesorectum is continuous with the sigmoid mesocolon. It is the segment of mesocolon that is attached to the upper third of the rectum posterolaterally and the inferior (lower) part circumferentially. Posterior / dorsal to (i.e., behind) the rectum and mesorectum is the presacral fascia, which covers the sacrum and coccyx. The lateral rectal ligaments (rectal stalks) are condensations of fascia (connective tissue) on either side of the rectum. They are located below the peritoneum and connect the rectum to the parietal pelvic fascia, providing structural support to the lower part of the rectum. They contain blood vessels, lymphatic vessels, and autonomic nerve fibers from the inferior hypogastric plexus.

Sources: en.wikipedia.org

Further detail

=== US market === In the United States, sales of jerky snacks increased significantly, rising by 10.4% in 2024 to reach $3.29 billion. This growth can be attributed to the rising popularity of salty and spicy snacks and a growing interest in snackable protein sources. As a result, dried meat snacks have emerged as the fastest-growing category within the United States snack food market.

Type 1 diabetes can develop at any age, with a peak in onset during childhood and adolescence. Adult onsets on the other hand are often initially misdiagnosed as having type 2. The major sign of type 1 diabetes include high blood sugar, which typically manifests in children as a few days to weeks of polyuria (increased urination), polydipsia (increased thirst), and weight loss after being exposed to a triggering factor including infections, strenuous exercise, or dehydration. Children may also experience increased appetite, blurred vision, bedwetting, recurrent skin infections, candidiasis of the perineum, irritability, and reduced mental acumen. Adults with type 1 diabetes tend to have more varied symptoms, which come on over months, rather than days or weeks. Prolonged lack of insulin can cause diabetic ketoacidosis, the signs of which include fruity breath odor, mental confusion, persistent fatigue, dry or flushed skin, abdominal pain, nausea or vomiting, and labored breathing. Blood and urine tests reveal high glucose and ketones. Untreated ketoacidosis can rapidly progress to loss of consciousness, coma, and death. The percentage of children whose type 1 diabetes begins with an episode of diabetic ketoacidosis varies widely by geography, as low as 15% in parts of Europe and North America, and as high as 80% in the developing world.

Their gendered differences were not acknowledged in diagrams of the human body. Medical texts such as the Yuzuan yizong jinjian were filled with illustrations of male bodies or androgynous bodies that did not display gendered characteristics. As in other cultures, fertility and menstruation dominate female health concerns. Since male and female bodies were governed by the same forces, traditional Chinese medicine did not recognize the womb as the place of reproduction. The abdominal cavity presented pathologies that were similar in both men and women, which included tumors, growths, hernias, and swellings of the genitals. The "master system", as Charlotte Furth calls it, is the kidney visceral system, which governed reproductive functions. Therefore, it was not the anatomical structures that allowed for pregnancy, but the difference in processes that allowed for the condition of pregnancy to occur.

Sources: en.wikipedia.org

Background from the literature

== Pure substances == When pure substances (liquids or solids) are involved in equilibria their activities do not appear in the equilibrium constant because their numerical values are considered one. Applying the general formula for an equilibrium constant to the specific case of a dilute solution of acetic acid in water one obtains

==== Antistatic agents ==== Ionic surfactants also function as external antistatic agents to prevent electrostatic charging of plastic surfaces (ESD protection). Both anionic and cationic surfactants are used for this purpose[9].

=== Contest history === 2009 NABBA England - 2nd 2009 NABBA Universe - 2nd 2009 UKBFF Hercules - 1st 2010 UKBFF British Championships - 1st 2011 Arnold Amateur Europe - 4th 2011 Women's World Amateur Championships - 4th (HW) 2013 Arnold Amateur Europe - 2nd 2014 IFBB Tampa Pro - 16th 2015 IFBB Omaha Pro - 1st 2015 IFBB Wings of Strength Rising Phoenix World Championships - 9th 2016 IFBB Tampa Pro - 2nd 2016 IFBB Wings of Strength Rising Phoenix World Championships – 7th 2017 IFBB Tampa Pro - 2nd 2017 IFBB WOS Rising Phoenix World Championships – 9th 2018 IFBB Tampa Pro - 4th 2019 IFBB Romania Muscle Fest Pro - 6th 2022 IFBB WOS Rising Phoenix World Championships – 14th

While the presence of a moonlighting protein in an unexpected location may complicate routine analyses, at the same time, the detection of a protein in unexpected multiprotein complexes or locations suggests that protein may have a moonlighting function. Furthermore, mass spectrometry may be used to determine if a protein has high expression levels that do not correlate to the enzyme's measured metabolic activity. These expression levels may signify that the protein is performing a different function than previously known. The structure of a protein can also help determine its functions. Protein structure in turn may be elucidated with various techniques including X-ray crystallography or NMR. Dual-polarization interferometry may be used to measure changes in protein structure which may also give hints to the protein's function. Finally, application of systems biology approaches such as interactomics give clues to a proteins function based on what it interacts with.

Sources: en.wikipedia.org

Frequently asked questions

Is thymosin alpha-1 a naturally occurring hormone?

It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.

What is the difference between thymosin alpha-1 and other thymosins?

Thymosin alpha-1 is a single defined 28-residue peptide, while the broader family includes unrelated peptides such as thymosin beta-4. The shared name reflects historical isolation from thymus tissue rather than a common structure. Confusion between the two is common in older literature.

Does the peptide work by a single known mechanism?

No single pathway fully accounts for its reported effects. Several studies describe interaction with innate immune receptors and downstream cytokine changes, but the complete picture is not settled. Open questions remain about which effects occur at physiological concentrations.

Is thymosin alpha-1 a hormone?

It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.

Network